Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Measurable Residual Disease Monitoring during Treatment for Pediatric Acute Myeloid Leukemia in First Relapse Predicts Outcome

Camilla Poulsen, Kristian Juul Sandahl, Lene Karlsson, Jonas Abrahamsson, Nira Arad-Cohen, Daniel Cheuk, Barbara De Moerloose, Jose Maria Fernandez Navarro, Kirsi Jahnukainen, Gertjan J.L. Kaspers, Zhanna Kovalova, Monica Cheng Munthe-Kaas, Ulrika Norén-Nyström, Josefine Palle, Ramune Pasauliene, Cornelis Jan Pronk, Kadri Saks, Kristian Juul-Dam, Henrik Hasle

Blood (2024) 144 (Supplement 1): 323.

https://doi.org/10.1182/blood-2024-193741

Published: 2024

Journal Articles

Comparison of the WHO and ICC Classifications of Cytogenetic Abnormalities in Childhood Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 322.

https://doi.org/10.1182/blood-2024-193878

Published: 2024

Journal Articles

Presence of Leukemia-Related Basophils and Mast Cells with Atypical Immunophenotype during Induction Should Not be Interpreted As Measurable Residual Disease in Children with Acute Myeloid Leukemia with RUNX1 :: RUNX1T1

Blood (2024) 144 (Supplement 1): 2954.

https://doi.org/10.1182/blood-2024-199996

Published: 2024

Journal Articles

A Randomized Comparison of Liposomal Daunorubicin/Daunorubicin Combined with Low-Dose Cytarabine and Etoposide or High-Dose Cytarabine and Fludarabine in Induction Treatment of Pediatric AML Using MRD-Based Risk Stratification in the NOPHO-DBH AML 2012 Protocol

Barbara De Moerloose, Nira Arad-Cohen, Daniel Cheuk, Jose Maria Fernandez Navarro, Henrik Hasle, Kirsi Jahnukainen, Gertjan J.L. Kaspers, Zhanna Kovalova, Birgitte Lausen, Ulrika Norén-Nyström, Josefine Palle, Ramune Pasauliene, Cornelis Jan Pronk, Kadri Saks, Anne Maria Tierens, Bernward Zeller, Jonas Abrahamsson

Blood (2023) 142 (Supplement 1): 831.

https://doi.org/10.1182/blood-2023-187251

Published: 2023

Journal Articles

The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia

Blood (2023) 141 (23): 2853–2866.

https://doi.org/10.1182/blood.2022019425

Published: 2023

Includes: Supplemental data

Journal Articles

Association of unbalanced translocation der(1;7) with germline GATA2 mutations

Blood (2021) 138 (23): 2441–2445.

https://doi.org/10.1182/blood.2021012781

Published: 2021

Includes: Supplemental data

Journal Articles

Patient-Tailored Measurable Residual Disease Monitoring in Peripheral Blood Using Deep Sequencing and Droplet Digital PCR for Early Detection of Relapse in Childhood Acute Myeloid Leukemia: A NOPHO-DBH Collaborative Study

Anne-Sofie Skou, Kristian Løvvik Juul-Dam, Erik Delsing Malmberg, Anna Rehammar, Anastasia Soboli, Azadeh Anbarlou, Erik Kristiansson, Jonas Abrahamsson, Bernward Zeller, Kirsi Jahnukainen, Edwin Sonneveld, Birgitte Lausen, Anni Aggerholm, Hans Beier Ommen, Henrik Hasle, Linda Fogelstrand

Blood (2021) 138 (Supplement 1): 3457.

https://doi.org/10.1182/blood-2021-153411

Published: 2021

Journal Articles

NF1 Tumor Suppressor Gene Inactivation in Juvenile Myelomonocytic Leukemia: New Genetic Evidence and Consequences for Diagnostic Work-up

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-136294

Published: 2020

Journal Articles

Genomic and Transcriptomic Characterization of Adult and Pediatric Relapsed Acute Myeloid Leukemia Reveals Novel Therapeutic Targets

Svea Stratmann, Sara A Yones, Jitong Sun, PhD, Aron Skaftason, Markus Mayrhofer, PhD, Nina Norgren, PhD, Morten Krogh Herlin, MD, Anna Eriksson, PhD, Martin Hoglund, MD, Josefine Palle, PhD, Kirsi Jahnukainen, MD PhD, Katja Pokrovskaja Tamm, PhD, Lucia Cavelier, PhD, Linda Holmfeldt, PhD

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-139427

Published: 2020

Journal Articles

Germline Gene Aberrations Are Common in High-Risk Adult and Pediatric Acute Lymphoblastic Leukemia Patients

Suvi Douglas, MSc, Atte Lahtinen, BM, Jessica Koski, BSc, Lilli Leimi, MD, Mikko A Keränen, MD PhD, Kimmo Porkka, Caroline A Heckman, PhD, Kirsi Jahnukainen, MD PhD, Outi Kilpivaara, PhD, Ulla Wartiovaara-Kautto, MD PhD

Blood (2019) 134 (Supplement_1): 1472.

https://doi.org/10.1182/blood-2019-126657

Published: 2019

Journal Articles

Patient-Tailored Deep Sequencing of Peripheral Blood Enables Early Detection of Relapse in Childhood Acute Myeloid Leukemia

Kristian Løvvik Juul-Dam, MD, Erik Delsing Malmberg, Anna Rehammar, Erik Kristiansson, Jonas Abrahamsson, Anni Aggerholm, Marta Maria Dirdal, Kirsi Jahnukainen, Birgitte Lausen, Hans Beier Ommen, Henrik Hasle, Linda Fogelstrand

Blood (2019) 134 (Supplement_1): 1456.

https://doi.org/10.1182/blood-2019-124970

Published: 2019

Journal Articles

Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia

Kristian Juul-Dam, MD, Hans Beier Ommen, Charlotte Guldborg Nyvold, Christiane Walter, Helen Vålerhaugen, Veli Kairisto, Jonas Abrahamsson, Sofie Johansson Alm, Kirsi Jahnukainen, Birgitte Lausen, Dirk Reinhardt, Bernward Zeller, Nils Von Neuhoff, Linda Fogelstrand, MD PhD, Henrik Hasle, MD

Blood (2018) 132 (Supplement 1): 2754.

https://doi.org/10.1182/blood-2018-99-119642

Published: 2018

Journal Articles

SAMD9 and SAMD9L Germline Disorders in Patients Enrolled in Studies of the European Working Group of MDS in Childhood (EWOG-MDS): Prevalence, Outcome, Phenotype and Functional Characterisation

Blood (2018) 132 (Supplement 1): 643.

https://doi.org/10.1182/blood-2018-99-118389

Published: 2018

Journal Articles

Hypodiploidy in Childhood Acute Myeloid Leukemia: A Retrospective Cohort Study within the International Berlin-Frankfurt-Münster Study Group

Blood (2018) 132 (Supplement 1): 1466.

https://doi.org/10.1182/blood-2018-99-109988

Published: 2018

Journal Articles

Large Granular Lymphocyte Infiltration in the Bone Marrow in Children and Young Adults May Suggest Primary Immune Deficiency

Mervi H Taskinen, MD PhD, Satu Mustjoki, MD PhD, Kirsi Jahnukainen, MD PhD, Luca Trotta, MSc, Timo Siitonen, MD PhD, Timo Hautala, MD PhD, Andrey Zavialov, PhD, Kaarina Heiskanen, MD PhD, Emma M Haapaniemi, MD PhD, Janna Saarela, MD PhD, Mikko Seppänen, MD PhD

Blood (2015) 126 (23): 1024.

https://doi.org/10.1182/blood.V126.23.1024.1024

Published: 2015

Journal Articles

qPCR MRD Monitoring in Peripheral Blood May Predict Hematological Relapse in Pediatric Acute Myeloid Leukemia

Kristian L Juul-Dam, MD, Charlotte G Nyvold, PhD, Hans B Ommen, MD PhD, Olafur G Jonsson, MD, Birgitte Lausen, MD, Kirsi Jahnukainen, MD PhD, Henrik Hasle, MD

Blood (2015) 126 (23): 3749.

https://doi.org/10.1182/blood.V126.23.3749.3749

Published: 2015

Journal Articles

Anthracycline Type during Induction Associated with Outcome in Pediatric t(8;21) and Inv(16) AML

Henrik Hasle, Jonas Abrahamsson, MD PhD, Evelina S De Bont, MDPhD, Valerie de Haas, Barbara De Moerloose, Erik Forestier, MD PhD, Shau Yin Ha, Jesper Heldrup, Kirsi Jahnukainen, Ólafur G Jónsson, MD, Birgitte Lausen, MD, Josefine Palle, MD PhD, Ardine Reedijk, MSc, Kadri Saks, MD, Bernward Zeller

Blood (2014) 124 (21): 11.

https://doi.org/10.1182/blood.V124.21.11.11

Published: 2014

Journal Articles

The Applicability Of The WHO Classification In Pediatric AML. A NOPHO-AML Study

Julie Damgaard Sandahl, Eigil Kjeldsen, Jonas Abrahamsson, Shau-Yin Ha, Jesper Heldrup, Kirsi Jahnukainen, Ólafur G Jónsson, Birgitte Lausen, Josefine Palle, Bernward Zeller, Erik Forestier, Henrik Hasle

Blood (2013) 122 (21): 1354.

https://doi.org/10.1182/blood.V122.21.1354.1354

Published: 2013

Journal Articles

Risk of Thrombosis with Different Approaches to Central Venous Access During Acquired Asparaginase Related Antithrombin Deficiency in Children with Leukemia.

Susanna Ranta, MD, PhD, Mats Heyman, MD, PhD, Kirsi Jahnukainen, MD, PhD, Mervi Taskinen, MD, PhD, Ulla M. Saarinen-Pihkala, Tony Frisk, MD, PhD, Stefan Söderhäll, MD, PhD, Pia Petrini, MD, Anne Mäkipernaa, MD, PhD

Blood (2012) 120 (21): 2241.

https://doi.org/10.1182/blood.V120.21.2241.2241

Published: 2012

Journal Articles

Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004

Henrik Hasle, Jonas Abrahamsson, Erik Forestier, Shau-Yin Ha, Jesper Heldrup, Kirsi Jahnukainen, Ólafur Gísli Jónsson, Birgitte Lausen, Josefine Palle, Bernward Zeller

Blood (2012) 120 (5): 978–984.

https://doi.org/10.1182/blood-2012-03-416701

Published: 2012

Includes: Supplemental data

NARROW

Measurable Residual Disease Monitoring during Treatment for Pediatric Acute Myeloid Leukemia in First Relapse Predicts Outcome

Comparison of the WHO and ICC Classifications of Cytogenetic Abnormalities in Childhood Acute Myeloid Leukemia

Presence of Leukemia-Related Basophils and Mast Cells with Atypical Immunophenotype during Induction Should Not be Interpreted As Measurable Residual Disease in Children with Acute Myeloid Leukemia with RUNX1 :: RUNX1T1

A Randomized Comparison of Liposomal Daunorubicin/Daunorubicin Combined with Low-Dose Cytarabine and Etoposide or High-Dose Cytarabine and Fludarabine in Induction Treatment of Pediatric AML Using MRD-Based Risk Stratification in the NOPHO-DBH AML 2012 Protocol

The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia

Association of unbalanced translocation der(1;7) with germline GATA2 mutations

Patient-Tailored Measurable Residual Disease Monitoring in Peripheral Blood Using Deep Sequencing and Droplet Digital PCR for Early Detection of Relapse in Childhood Acute Myeloid Leukemia: A NOPHO-DBH Collaborative Study

NF1 Tumor Suppressor Gene Inactivation in Juvenile Myelomonocytic Leukemia: New Genetic Evidence and Consequences for Diagnostic Work-up

Genomic and Transcriptomic Characterization of Adult and Pediatric Relapsed Acute Myeloid Leukemia Reveals Novel Therapeutic Targets

Germline Gene Aberrations Are Common in High-Risk Adult and Pediatric Acute Lymphoblastic Leukemia Patients

Patient-Tailored Deep Sequencing of Peripheral Blood Enables Early Detection of Relapse in Childhood Acute Myeloid Leukemia

Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia

SAMD9 and SAMD9L Germline Disorders in Patients Enrolled in Studies of the European Working Group of MDS in Childhood (EWOG-MDS): Prevalence, Outcome, Phenotype and Functional Characterisation

Hypodiploidy in Childhood Acute Myeloid Leukemia: A Retrospective Cohort Study within the International Berlin-Frankfurt-Münster Study Group

Large Granular Lymphocyte Infiltration in the Bone Marrow in Children and Young Adults May Suggest Primary Immune Deficiency

qPCR MRD Monitoring in Peripheral Blood May Predict Hematological Relapse in Pediatric Acute Myeloid Leukemia

Anthracycline Type during Induction Associated with Outcome in Pediatric t(8;21) and Inv(16) AML

The Applicability Of The WHO Classification In Pediatric AML. A NOPHO-AML Study

Risk of Thrombosis with Different Approaches to Central Venous Access During Acquired Asparaginase Related Antithrombin Deficiency in Children with Leukemia.

Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only